The anti-inflammatory effects of cholinergic stimulation, utilizing α7nAChR agonists such as nicotine and GTS-21 on AKI, have been demonstrated in several preclinical studies, primarily in models of sepsis-induced AKI and renal ischemia-reperfusion injury [19]. This evidence concerns the gene CHRNA7 and acute kidney injury.